Structures of filaments from Pick's disease reveal a novel tau protein fold
Benjamin Falcon, Wenjuan Zhang, Alexey G Murzin, Garib Murshudov, Holly J Garringer, Ruben Vidal, R Anthony Crowther, Bernardino Ghetti, Sjors H W Scheres, Michel Goedert, Benjamin Falcon, Wenjuan Zhang, Alexey G Murzin, Garib Murshudov, Holly J Garringer, Ruben Vidal, R Anthony Crowther, Bernardino Ghetti, Sjors H W Scheres, Michel Goedert
Abstract
The ordered assembly of tau protein into abnormal filamentous inclusions underlies many human neurodegenerative diseases1. Tau assemblies seem to spread through specific neural networks in each disease2, with short filaments having the greatest seeding activity3. The abundance of tau inclusions strongly correlates with disease symptoms4. Six tau isoforms are expressed in the normal adult human brain-three isoforms with four microtubule-binding repeats each (4R tau) and three isoforms that lack the second repeat (3R tau)1. In various diseases, tau filaments can be composed of either 3R or 4R tau, or of both. Tau filaments have distinct cellular and neuroanatomical distributions5, with morphological and biochemical differences suggesting that they may be able to adopt disease-specific molecular conformations6,7. Such conformers may give rise to different neuropathological phenotypes8,9, reminiscent of prion strains10. However, the underlying structures are not known. Using electron cryo-microscopy, we recently reported the structures of tau filaments from patients with Alzheimer's disease, which contain both 3R and 4R tau11. Here we determine the structures of tau filaments from patients with Pick's disease, a neurodegenerative disorder characterized by frontotemporal dementia. The filaments consist of residues Lys254-Phe378 of 3R tau, which are folded differently from the tau filaments in Alzheimer's disease, establishing the existence of conformers of assembled tau. The observed tau fold in the filaments of patients with Pick's disease explains the selective incorporation of 3R tau in Pick bodies, and the differences in phosphorylation relative to the tau filaments of Alzheimer's disease. Our findings show how tau can adopt distinct folds in the human brain in different diseases, an essential step for understanding the formation and propagation of molecular conformers.
Conflict of interest statement
Author Information
The authors declare no competing interests.
Figures
References
- Goedert M, Eisenberg DS & Crowther RA Propagation of tau aggregates and neurodegeneration. Annu. Rev. Neurosci 40, 189–210 (2017).
- Braak H & Del Tredici K Potential pathways of abnormal tau and alpha-synuclein dissemination in sporadic Alzheimer’s and Parkinson’s diseases. Cold Spring Harb. Perspect. Biol 8, a023630 (2016).
- Jackson SJ et al. Short fibrils constitute the major species of seed-competent tau in the brains of mice transgenic for human P301S tau. J. Neurosci 36, 762–772 (2016).
- Wilcock GK & Esiri MM Plaques, tangles and dementia. A quantitative study. J. Neurol. Sci 56, 343–356 (1982).
- Ghetti B et al. Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol. Appl. Neurobiol 41, 24–46 (2015).
- Crowther RA & Goedert M Abnormal tau-containing filaments in neurodegenerative diseases. J. Struct. Biol 130, 271–279 (2000).
- Taniguchi-Watanabe S et al. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol. 131, 267–280 (2016).
- Clavaguera F et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl Acad. Sci. U S A 110, 9535–9540 (2013).
- Narasimhan S et al. Pathological tau strains from human brains recapitulate the diversity of tauopathies in nontransgenic mouse brain. J. Neurosci 37, 11406–11423 (2017).
- Collinge J Mammalian prions and their wider relevance in neurodegenerative diseases. Nature 539, 217–226 (2016).
- Fitzpatrick AWP et al. Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature 547, 185–190 (2017).
- Rasool CG & Selkoe DJ Sharing of specific antigens by degenerating neurons in Pick’s disease and Alzheimer’s disease. N. Engl. J. Med 312, 700–705 (1985).
- Pollock NJ, Mirra SS, Binder LI, Hansen LA & Wood JG Filamentous aggregates in Pick’s disease, progressive supranuclear palsy, and Alzheimer’s disease share antigenic determinants with microtubule-associated protein, tau. Lancet 328, 1211 (1986).
- Probst A, Tolnay M, Langui D, Goedert M & Spillantini MG Pick’s disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta. Neuropathol 92, 588–596 (1996).
- Delacourte A et al. Specific pathological tau protein variants characterize Pick’s disease. J. Neuropathol. Exp. Neurol 55, 159–168 (1996).
- Delacourte A, Sergeant N, Wattez A, Gauvreau D & Robitaille Y Vulnerable neuronal subsets in Alzheimer’s and Pick’s disease are distinguished by their tau isoform distribution and phosphorylation. Ann. Neurol 43, 193–204 (1998).
- Munoz DG, Morris HR & Rossor M Pick’s Disease. In Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders (eds Dickson DW & Weller RO) pp. 156–164 (Wiley-Blackwell, 2011).
- Wischik CM et al. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl Acad. Sci. U S A 85, 4884–4888 (1988).
- Rewcastle NB & Ball MJ Electron microscopic structure of the “inclusion bodies” in Pick’s disease. Neurology 18, 1205–1213 (1968).
- Schochet SS, Lampert PW & Lindenberg R Fine structure of the Pick and Hirano bodies in a case of Pick’s disease. Acta Neuropathol. 11, 330–337 (1968).
- Wisniewski HM, Coblentz JM & Terry RD Pick’s disease. A clinical and ultrastructural study. Arch. Neurol 26, 97–108 (1972).
- He S & Scheres SHW Helical reconstruction in RELION. J. Struct. Biol 198, 163–176 (2017).
- Crowther RA Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc. Natl Acad. Sci. U S A 88, 2288–2292 (1991).
- Jicha GA, Bowser R, Kazam IG & Davies P Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res 48, 128–132 (1997).
- Guo JL et al. Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice. J. Exp. Med 213, 2635–2654 (2016).
- Sanders DW et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271–1288 (2014).
- Seeley WW et al. Early frontotemporal dementia targets neurons unique to apes and humans. Ann. Neurol 60, 660–667 (2006).
- Miki Y et al. An autopsy case of incipient Pick’s disease: immunohistochemical profile of early-stage Pick body formation. Neuropathology 34, 386–391 (2014).
- Goedert M, Spillantini MG, Potier MC, Ulrich J & Crowther RA Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. Embo J. 8, 393–399 (1989).
- Goedert M, Spillantini MG, Jakes R, Rutherford D & Crowther RA Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3, 519–526 (1989).
- Wasmer C et al. Amyloid fibrils of the HET-s(218–289) prion form a beta solenoid with a triangular hydrophobic core. Science 319, 1523–1526 (2008).
- Goedert M, Yamaguchi Y, Mishra SK, Higuchi M & Sahara N Tau Filaments and the Development of Positron Emission Tomography Tracers. Front. Neurol 9, 70 (2018).
- Goedert M, Spillantini MG, Cairns NJ & Crowther RA Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159–168 (1992).
- Falcon B et al. Conformation determines the seeding potencies of native and recombinant Tau aggregates. J. Biol. Chem 290, 1049–1065 (2015).
- Spina S et al. The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain 131, 72–89 (2008).
- Farlow JL et al. Whole-exome sequencing in familial Parkinson disease. JAMA Neurol. 73, 68–75 (2016).
- Saijo E et al. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid. Acta Neuropathol. 133, 751–765 (2017).
- Zheng SQ et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
- Zhang K Gctf: Real-time CTF determination and correction. J. Struct. Biol 193, 1–12 (2016).
- Scheres SH RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol 180, 519–530 (2012).
- Fernandez-Leiro R & Scheres SH Unravelling biological macromolecules with cryo-electron microscopy. Nature 537, 339–346 (2016).
- Chen S et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24–35 (2013).
- Emsley P, Lohkamp B, Scott WG & Cowtan K Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
- Adams PD et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).
- Murshudov GN, Vagin AA & Dodson EJ Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240–255 (1997).
- Chen VB et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).
- Seubert P et al. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J. Biol. Chem 270, 18917–18922 (1995).
- Litersky JM et al. Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochem. J 316 ( Pt 2), 655–660 (1996).
Source: PubMed